Added by | liaudet-coopman |
---|---|
Group name | EquipeELC |
Item Type | Attachment |
Title | Texte intégral |
URL | https://academic.oup.com/annonc/article-pdf/25/8/1570/763205/mdu183.pdf |
Accessed | 2019/05/29 - 15:14:47 |
Date Added | 2019/05/29 - 13:14:47 |
Date Modified | 2019/05/29 - 13:14:47 |
Parent item | Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact |